31 – 40 of 68
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
STROMA-DERIVED MARKERS PREDICTING BREAST CANCER PROGNOSIS AND TREATMENT RESPONSE
(
- Contribution to journal › Published meeting abstract
-
Mark
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Expression of the translation regulatory protein RBM3 is associated with a favourable prognosis in epithelial ovarian cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
(
- Contribution to journal › Article
-
Mark
Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
(
- Contribution to journal › Article
-
Mark
Down-Regulation of the Oncogene Cyclin D1 Increases Migratory Capacity in Breast Cancer and Is Linked to Unfavorable Prognostic Features.
(
- Contribution to journal › Article
-
Mark
p27(Kip1) is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.
(
- Contribution to journal › Article
- 2009
-
Mark
JAM-A expression positively correlates with poor prognosis in breast cancer patients
(
- Contribution to journal › Article
-
Mark
Differential expression of cytoplasmic and stromal beta-arrestin-1 is associated with separate aspects of tumor behavior in breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer
(
- Contribution to journal › Article